• Home
  • News & Resources
  • All T2Candida Panel
  • T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study

T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study

Share the post "T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study"

  • Media Contact

    Gina Kent
    610-455-2763
    gkent@vaultcommunications.com

    Media Center

  • According to the CDC, of the 154 million prescriptions for antibiotics written in doctors' offices and emergency departments each year, 30% are unnecessary.12

  • Publications

    Over 200 studies published in peer-reviewed journals have featured T2MR in a breadth of applications.

    Read Now!